M61.176 Myositis ossificans progressiva, unspecified foot

Name of the Condition

• Myositis Ossificans Progressiva, Unspecified Foot

Summary

Myositis ossificans progressiva is a rare genetic disorder characterized by the progressive formation of heterotopic bone within muscle, tendons, and ligaments. When localized to the foot, this process leads to gradual replacement of soft tissue with bone, resulting in restricted movement, pain, and functional impairment over time. The condition typically begins in childhood and worsens with age, affecting the musculotendinous structures of the lower extremity.

Causes

The condition is caused by mutations in the ACVR1 gene, which disrupts normal bone and muscle development. These genetic changes disrupt signaling pathways, leading to uncontrolled bone formation in soft tissues. The disorder follows an autosomal dominant inheritance pattern, though most cases arise from new mutations.

Risk Factors

• Family history of the condition
• Presence of ACVR1 gene mutations
• Young age at onset (typically in childhood)
• Trauma or minor injury to the foot area

Symptoms

• Progressive stiffness and limited range of motion in the foot
• Pain or discomfort in affected areas
• Visible swelling or hardening of soft tissues
• Difficulty with movement or daily activities (e.g., walking, standing)
• Flare-ups triggered by minor trauma

Diagnosis

Diagnosis involves clinical evaluation, genetic testing for ACVR1 mutations, and imaging studies (X-rays, CT, or MRI) to identify heterotopic bone formation in the foot. Clinical assessment focuses on the progressive nature of symptoms and exclusion of other causes of soft tissue ossification.

Treatment Options

Treatment aims to manage symptoms and slow progression. Options may include physical therapy to maintain mobility, pain management, and surgical intervention in severe cases to remove excess bone or release contractures. Genetic counseling is recommended for affected individuals and families.

Prognosis and Follow-Up

The condition is progressive, with gradual worsening of symptoms over time. Regular follow-up with a healthcare provider is essential to monitor disease progression, adjust treatment, and address complications. Early intervention may help preserve function, but long-term outcomes depend on the extent of bone formation and response to therapy.

Complications

• Severe restriction of foot movement or joint contractures
• Chronic pain and functional impairment
• Difficulty with weight-bearing or daily activities
• Potential for secondary injuries due to altered gait or mobility

Lifestyle & Prevention

While the genetic basis prevents prevention, managing symptoms through regular physical therapy, avoiding unnecessary trauma to the foot, and maintaining open communication with healthcare providers can help optimize quality of life. Adaptive devices may assist with mobility as the condition progresses.

When to Seek Professional Help

Seek medical attention if you experience progressive stiffness, pain, or swelling in the foot, especially if symptoms worsen or interfere with daily activities. Early evaluation is important for accurate diagnosis and timely intervention.

Tips for Medical Coders

Document the specific foot involvement (e.g., location, laterality) when available to support coding accuracy. For unspecified foot, use M61.176. Ensure clinical documentation aligns with the progressive nature of the condition and any genetic testing results to justify the diagnosis.